Thrivent Financial for Lutherans’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$882K Buy
11,828
+49
+0.4% +$3.65K ﹤0.01% 1859
2025
Q1
$749K Sell
11,779
-1,252,515
-99% -$79.6M ﹤0.01% 1884
2024
Q4
$98.7M Buy
1,264,294
+164,111
+15% +$12.8M 0.19% 127
2024
Q3
$88.4M Buy
1,100,183
+250,833
+30% +$20.2M 0.17% 160
2024
Q2
$70.3M Buy
849,350
+836,623
+6,574% +$69.2M 0.14% 188
2024
Q1
$1.09M Buy
12,727
+51
+0.4% +$4.35K ﹤0.01% 1865
2023
Q4
$1.08M Sell
12,676
-22
-0.2% -$1.88K ﹤0.01% 1793
2023
Q3
$1.14M Sell
12,698
-323
-2% -$28.9K ﹤0.01% 1662
2023
Q2
$1.11M Sell
13,021
-293
-2% -$25K ﹤0.01% 1738
2023
Q1
$1.1M Sell
13,314
-166
-1% -$13.7K ﹤0.01% 1723
2022
Q4
$1.06M Sell
13,480
-102
-0.8% -$8.02K ﹤0.01% 1695
2022
Q3
$1.01M Buy
13,582
+173
+1% +$12.8K ﹤0.01% 1683
2022
Q2
$874K Buy
13,409
+53
+0.4% +$3.46K ﹤0.01% 1794
2022
Q1
$844K Sell
13,356
-22,847
-63% -$1.44M ﹤0.01% 1924
2021
Q4
$1.92M Buy
36,203
+18,251
+102% +$968K ﹤0.01% 1422
2021
Q3
$1.27M Sell
17,952
-205
-1% -$14.5K ﹤0.01% 1677
2021
Q2
$1.21M Sell
18,157
-53,422
-75% -$3.56M ﹤0.01% 1721
2021
Q1
$7.95M Buy
71,579
+29,752
+71% +$3.3M 0.02% 748
2020
Q4
$4.97M Sell
41,827
-40,848
-49% -$4.85M 0.01% 870
2020
Q3
$7.21M Buy
82,675
+68,756
+494% +$6M 0.02% 695
2020
Q2
$1.25M Buy
13,919
+676
+5% +$60.6K ﹤0.01% 1351
2020
Q1
$1.32M Hold
13,243
﹤0.01% 1151
2019
Q4
$1.52M Buy
13,243
+61
+0.5% +$7.01K ﹤0.01% 1192
2019
Q3
$1.66M Sell
13,182
-371
-3% -$46.8K 0.01% 1101
2019
Q2
$1.63M Buy
13,553
+172
+1% +$20.7K 0.01% 1113
2019
Q1
$1.17M Buy
13,381
+247
+2% +$21.6K ﹤0.01% 1266
2018
Q4
$1.31M Buy
13,134
+543
+4% +$54.3K ﹤0.01% 1019
2018
Q3
$1.44M Buy
12,591
+696
+6% +$79.8K ﹤0.01% 1059
2018
Q2
$1.07M Sell
11,895
-24,118
-67% -$2.16M ﹤0.01% 1214
2018
Q1
$2.64M Buy
36,013
+3,420
+10% +$250K 0.01% 805
2017
Q4
$1.89M Buy
32,593
+643
+2% +$37.3K 0.01% 936
2017
Q3
$1.43M Buy
31,950
+190
+0.6% +$8.53K 0.01% 990
2017
Q2
$1.25M Sell
31,760
-128,600
-80% -$5.08M 0.01% 1010
2017
Q1
$6.51M Buy
160,360
+132,580
+477% +$5.38M 0.03% 505
2016
Q4
$1.12M Buy
27,780
+1,690
+6% +$68K 0.01% 1094
2016
Q3
$945K Buy
26,090
+1,330
+5% +$48.2K ﹤0.01% 1155
2016
Q2
$718K Sell
24,760
-64,510
-72% -$1.87M ﹤0.01% 1250
2016
Q1
$3.12M Buy
89,270
+67,510
+310% +$2.36M 0.02% 746
2015
Q4
$702K Buy
21,760
+710
+3% +$22.9K ﹤0.01% 1199
2015
Q3
$680K Buy
21,050
+950
+5% +$30.7K ﹤0.01% 1085
2015
Q2
$831K Buy
20,100
+1,100
+6% +$45.5K ﹤0.01% 887
2015
Q1
$853K Buy
19,000
+200
+1% +$8.98K ﹤0.01% 887
2014
Q4
$704K Buy
18,800
+50
+0.3% +$1.87K ﹤0.01% 953
2014
Q3
$655K Sell
18,750
-300
-2% -$10.5K ﹤0.01% 984
2014
Q2
$672K Buy
19,050
+150
+0.8% +$5.29K ﹤0.01% 1004
2014
Q1
$616K Buy
18,900
+100
+0.5% +$3.26K ﹤0.01% 864
2013
Q4
$792K Buy
18,800
+100
+0.5% +$4.21K ﹤0.01% 817
2013
Q3
$746K Hold
18,700
﹤0.01% 786
2013
Q2
$773 Buy
+18,700
New +$773 0.01% 762